SG11201404144PA - 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives - Google Patents
4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivativesInfo
- Publication number
- SG11201404144PA SG11201404144PA SG11201404144PA SG11201404144PA SG11201404144PA SG 11201404144P A SG11201404144P A SG 11201404144PA SG 11201404144P A SG11201404144P A SG 11201404144PA SG 11201404144P A SG11201404144P A SG 11201404144PA SG 11201404144P A SG11201404144P A SG 11201404144PA
- Authority
- SG
- Singapore
- Prior art keywords
- benzoimidazol
- thiazole compounds
- aza derivatives
- related aza
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IBPCT/IB2012/050489 | 2012-02-02 | ||
PCT/IB2013/050870 WO2013114332A1 (en) | 2012-02-02 | 2013-02-01 | 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201404144PA true SG11201404144PA (en) | 2014-10-30 |
Family
ID=48014121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201404144PA SG11201404144PA (en) | 2012-02-02 | 2013-02-01 | 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives |
Country Status (21)
Country | Link |
---|---|
US (1) | US9266876B2 (es) |
EP (1) | EP2809668B1 (es) |
JP (1) | JP6073931B2 (es) |
KR (1) | KR101800607B1 (es) |
CN (1) | CN104093715B (es) |
AU (1) | AU2013216354B2 (es) |
BR (1) | BR112014018714A8 (es) |
CA (1) | CA2861020C (es) |
CL (1) | CL2014002048A1 (es) |
EA (1) | EA027595B1 (es) |
ES (1) | ES2632237T3 (es) |
HK (1) | HK1203939A1 (es) |
IL (1) | IL233872A (es) |
MX (1) | MX352181B (es) |
MY (1) | MY170524A (es) |
NZ (1) | NZ629795A (es) |
PH (1) | PH12014501540B1 (es) |
PL (1) | PL2809668T3 (es) |
SG (1) | SG11201404144PA (es) |
UA (1) | UA113638C2 (es) |
WO (1) | WO2013114332A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR096984A1 (es) * | 2013-07-22 | 2016-02-10 | Actelion Pharmaceuticals Ltd | Derivados 1-(piperazin-1-il)-2-([1,2,4]triazol-1-il)-etanona |
CA2935944A1 (en) | 2014-01-09 | 2015-07-16 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone | Substituted benzoxazine and related compounds |
AR099789A1 (es) * | 2014-03-24 | 2016-08-17 | Actelion Pharmaceuticals Ltd | Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina |
US10053457B2 (en) * | 2015-01-15 | 2018-08-21 | Idorsia Pharmaceuticals Ltd. | Hydroxyalkyl-piperazine derivatives as CXCR3 receptor modulators |
AR103399A1 (es) | 2015-01-15 | 2017-05-10 | Actelion Pharmaceuticals Ltd | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3 |
GB201506658D0 (en) | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
GB201506660D0 (en) | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
WO2018011265A1 (en) | 2016-07-13 | 2018-01-18 | Idorsia Pharmaceuticals Ltd | Hydroxyalkyl-piperazine derivatives as cxcr3 receptor modulators |
FR3067028B1 (fr) | 2017-06-06 | 2019-07-12 | Adpuerivitam | Modulateurs de recepteurs nmda, compositions les comprenant et utilisation de ces composes dans le traitement de maladies impliquant le systeme nerveux central |
EP4228632A2 (en) * | 2020-10-16 | 2023-08-23 | Saint Louis University | Rev-erb agonists |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002059117A1 (en) | 2001-01-23 | 2002-08-01 | Eli Lilly And Company | Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
JP2005511475A (ja) | 2001-03-02 | 2005-04-28 | ブリストル−マイヤーズ スクイブ カンパニー | メラノコルチン受容体のモジュレーターとして有用な化合物及びそれを含む製薬組成物 |
GB0229618D0 (en) * | 2002-12-19 | 2003-01-22 | Cancer Rec Tech Ltd | Pyrazole compounds |
GB0315203D0 (en) | 2003-06-28 | 2003-08-06 | Celltech R&D Ltd | Chemical compounds |
WO2005035534A1 (ja) | 2003-10-08 | 2005-04-21 | Ono Pharmaceutical Co., Ltd. | 複素ビシクロ環および複素トリシクロ環化合物およびその医薬 |
US20050124625A1 (en) | 2003-10-21 | 2005-06-09 | Salvati Mark E. | Piperazine derivatives and their use as modulators of nuclear hormone receptor function |
WO2005042516A2 (en) | 2003-10-22 | 2005-05-12 | Neurocrine Biosciences, Inc. | Ligands of melanocortin receptors and compositions and methods related thereto |
GB0325956D0 (en) | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
AU2004293026B2 (en) | 2003-11-21 | 2012-01-19 | Array Biopharma Inc. | AKT protein kinase inhibitors |
MY140489A (en) | 2003-12-26 | 2009-12-31 | Eisai R&D Man Co Ltd | 1,2-di (cyclic) substituted benzene compounds |
US20060276465A1 (en) | 2003-12-26 | 2006-12-07 | Eisai R&D Management Co., Ltd. | 1,2-di(cyclic) substituted benzene compounds |
MX2007009949A (es) | 2005-02-16 | 2007-09-26 | Schering Corp | Pirazinil-piperazin-piperidinas sustituidas con heteroarilo con actividad antagonista de cxcr3. |
US7763616B2 (en) | 2005-02-16 | 2010-07-27 | Schering Corporation | Piperazine-piperidines with CXCR3 antagonist activity |
WO2006088920A1 (en) | 2005-02-16 | 2006-08-24 | Schering Corporation | Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
CN101142209A (zh) | 2005-02-16 | 2008-03-12 | 先灵公司 | 具有cxcr3拮抗剂活性的吡嗪基取代的哌嗪-哌啶 |
CN101146793A (zh) | 2005-02-16 | 2008-03-19 | 先灵公司 | 具有cxcr3拮抗剂活性的新的杂环取代了的吡啶或苯基化合物 |
US7776862B2 (en) | 2005-02-16 | 2010-08-17 | Schering Corporation | Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
KR20070107046A (ko) | 2005-02-16 | 2007-11-06 | 쉐링 코포레이션 | Cxcr3 길항제 활성을 지닌 헤테로사이클릭 치환된피페라진 |
KR20070113233A (ko) * | 2005-02-18 | 2007-11-28 | 아스트라제네카 아베 | 항균성 피페리딘 유도체 |
US20080312215A1 (en) | 2005-06-28 | 2008-12-18 | Pharmacopeia Drug Discovery, Inc. | Substituted [1,4]-diazepanes as CXCR3 antagonists and their use in the treatment of inflammatory disorders |
US7754724B2 (en) | 2005-06-30 | 2010-07-13 | Dow Agrosciences Llc | N-substituted piperazines |
TW200738701A (en) | 2005-07-26 | 2007-10-16 | Du Pont | Fungicidal carboxamides |
WO2007047202A1 (en) | 2005-10-11 | 2007-04-26 | Schering Corporation | Substituted heterocyclic compounds with cxcr3 antagonist activity |
US20090143413A1 (en) | 2005-11-29 | 2009-06-04 | Adams Alan D | Thiazole Derivatives as CXCR3 Receptor Modulators |
US20100286191A1 (en) * | 2005-12-12 | 2010-11-11 | Samuel Rachel G | 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators |
WO2007076318A2 (en) | 2005-12-21 | 2007-07-05 | Smithkline Beecham Corporation | Camphor-derived cxcr3 antagonists |
WO2007100610A2 (en) | 2006-02-23 | 2007-09-07 | Merck & Co., Inc. | Pyridine, pyrimidine and pyrazine derivatives as cxcr3 receptor modulators |
CN101460482B (zh) | 2006-03-21 | 2013-03-27 | 默沙东公司 | 具有cxcr3拮抗剂活性的杂环取代的吡啶化合物 |
FR2903405B1 (fr) | 2006-07-04 | 2011-09-09 | Pasteur Institut | Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications |
AU2007272884A1 (en) | 2006-07-14 | 2008-01-17 | Pharmacopeia, Inc. | Heterocyclic substituted piperazine compounds with CXCR3 antagonist activity |
WO2008013622A2 (en) | 2006-07-27 | 2008-01-31 | E. I. Du Pont De Nemours And Company | Fungicidal azocyclic amides |
CN101558066A (zh) * | 2006-08-17 | 2009-10-14 | 阿斯利康(瑞典)有限公司 | 具有抗菌活性的吡咯衍生物 |
AR064609A1 (es) | 2006-12-22 | 2009-04-15 | Schering Corp | Piperazinas sustituidas, composiciones farmaceuticas que las comprenden y su uso en el tratamiento de enfermedades mediadas por el receptor de quimiocinas cxcr3. |
AU2008207898B2 (en) | 2007-01-23 | 2012-05-03 | Xencor, Inc | Optimized CD40 antibodies and methods of using the same |
CN101622245B (zh) | 2007-01-25 | 2014-09-10 | 纳幕尔杜邦公司 | 杀真菌酰胺 |
CA2695365A1 (en) | 2007-08-03 | 2009-02-12 | Schering Corporation | Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines |
TWI428091B (zh) * | 2007-10-23 | 2014-03-01 | Du Pont | 殺真菌劑混合物 |
WO2009079490A1 (en) | 2007-12-18 | 2009-06-25 | Schering Corporation | Process and intermediates for the synthesis of heterocyclic substituted piperazines with cxcr3 antagonist activity |
ES2392014T3 (es) * | 2008-01-09 | 2012-12-03 | Array Biopharma, Inc. | Pirazolopiridinas como inhibidores de la cinasa |
AU2009206522B2 (en) | 2008-01-25 | 2013-12-19 | E. I. Du Pont De Nemours And Company | Fungicidal amides |
AU2009206468B2 (en) | 2008-01-25 | 2014-01-09 | E. I. Du Pont De Nemours And Company | Fungicidal heterocyclic compounds |
PE20091576A1 (es) | 2008-02-19 | 2009-11-05 | Sanofi Aventis | DERIVADOS DE 3-(AMIDO O SULFAMIDO)-4-(4-AZINIL SUSTITUIDO)BENZAMIDA COMO INHIBIDORES DEL RECEPTOR DE QUIMIOQUINAS CxCR3 |
AU2009243401A1 (en) | 2008-04-30 | 2009-11-05 | Bayer Cropscience Ag | Thiazol-4-carboxylic acid esters and thioesters as plant protection agents |
CN102159213B (zh) * | 2008-09-11 | 2015-05-27 | 凯莫森特里克斯股份有限公司 | 4-氨基-3-(咪唑基)-吡唑并[3,4-b]嘧啶 |
EP2334669B1 (de) | 2008-10-01 | 2015-12-23 | Bayer Intellectual Property GmbH | Heterocyclyl substituierte thiazole als pflanzenschutzmittel |
KR101052065B1 (ko) | 2008-10-15 | 2011-07-27 | 한국과학기술연구원 | 칼슘이온 채널 조절제로서 유효한 피라졸릴메틸아민-피페라진 유도체와 이의 제조방법 |
BRPI0914405B8 (pt) | 2008-12-02 | 2022-12-06 | Du Pont | Compostos de piperidina carboxamida fungicidas e métodos para o controle de doenças de planta |
WO2010066353A1 (de) | 2008-12-11 | 2010-06-17 | Bayer Cropscience Ag | Thiazolyoximether und -hydrazone asl pflanzenschutzmittel |
WO2010126811A1 (en) * | 2009-04-27 | 2010-11-04 | Boehringer Ingelheim International Gmbh | Cxcr3 receptor antagonists |
US8362249B2 (en) | 2009-04-27 | 2013-01-29 | Boehringer Ingelheim International Gmbh | CXCR3 receptor antagonists |
EP2272846A1 (de) | 2009-06-23 | 2011-01-12 | Bayer CropScience AG | Thiazolylpiperidin Derivate als Fungizide |
UA107938C2 (en) | 2009-08-12 | 2015-03-10 | Syngenta Participations Ag | Heterocycles with microbicidal properties |
CN102596943A (zh) | 2009-08-12 | 2012-07-18 | 先正达参股股份有限公司 | 杀灭微生物杂环类化合物 |
WO2011051243A1 (en) | 2009-10-29 | 2011-05-05 | Bayer Cropscience Ag | Active compound combinations |
EP2493886B1 (de) | 2009-10-30 | 2014-11-26 | Bayer CropScience AG | Heteroarylpiperidin und -piperazin derivate |
KR101808074B1 (ko) | 2009-12-21 | 2017-12-12 | 바이엘 크롭사이언스 악티엔게젤샤프트 | 살진균제로 사용되는 비스(디플루오로메틸)피라졸 |
WO2011084985A1 (en) | 2010-01-07 | 2011-07-14 | Boehringer Ingelheim International Gmbh | Cxcr3 receptor antagonists |
WO2011134969A1 (de) | 2010-04-28 | 2011-11-03 | Bayer Cropscience Ag | Ketoheteroarylpiperidin und -piperazin derivate als fungizide |
US8815775B2 (en) | 2010-05-18 | 2014-08-26 | Bayer Cropscience Ag | Bis(difluoromethyl)pyrazoles as fungicides |
WO2011146182A1 (en) | 2010-05-20 | 2011-11-24 | E. I. Du Pont De Nemours And Company | Fungicidal oximes and hydrazones |
EP2576539B1 (de) | 2010-05-27 | 2017-12-13 | Bayer CropScience AG | Pyridinylcarbonsäure derivate als fungizide |
US20120122928A1 (en) | 2010-08-11 | 2012-05-17 | Bayer Cropscience Ag | Heteroarylpiperidine and -Piperazine Derivatives as Fungicides |
US8759527B2 (en) | 2010-08-25 | 2014-06-24 | Bayer Cropscience Ag | Heteroarylpiperidine and -piperazine derivatives as fungicides |
BR112013010497B1 (pt) | 2010-10-27 | 2018-07-17 | Bayer Intellectual Property Gmbh | derivados de heteroaril - piperidina e - piperazina enquanto fungicidas, composição os compreendendo, bem como processo para a produção de composições para controle de fungos fitopatogênicos nocivos e método para controle de fungos fitopatogênicos nocivos |
WO2012069633A1 (en) | 2010-11-25 | 2012-05-31 | Syngenta Participations Ag | Microbicidal heterocycles |
BR112013015166A2 (pt) | 2010-12-17 | 2016-07-12 | Du Pont | composto selecionado a partir de fórmula 1, composição fungicida e método para controlar doenças de plantas |
CN104987330B (zh) | 2011-02-01 | 2019-04-05 | 拜耳知识产权有限责任公司 | 作为杀真菌剂的杂芳基哌啶和杂芳基哌嗪衍生物 |
US20130317064A1 (en) | 2011-02-10 | 2013-11-28 | Syngenta Participations Ag | Microbiocidal pyrazole derivatives |
EP2673264A1 (en) | 2011-02-10 | 2013-12-18 | Syngenta Participations AG | Microbiocidal pyrazole derivatives |
CN102827073A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
BR112014005989B1 (pt) | 2011-09-15 | 2019-11-05 | Bayer Ip Gmbh | compostos fungicidas piperidina-pirazoles, seus usos, método e composição para controlar fungos fitopatogênicos prejudiciais, e método para produzir composições |
EP2768828A1 (en) | 2011-10-18 | 2014-08-27 | Syngenta Participations AG | Microbiocidal pyrazole derivatives |
US20140228372A1 (en) | 2011-10-18 | 2014-08-14 | Syngenta Participations Ag | Microbiocidal pyrazole derivatives |
US8642774B2 (en) | 2011-12-08 | 2014-02-04 | Boehringer Ingelheim International Gmbh | Compounds |
IN2012DE00620A (es) | 2012-03-02 | 2015-08-21 | Syngenta Participations Ag | |
IN2012DE00621A (es) | 2012-03-02 | 2015-07-17 | Syngenta Participations Ag | |
WO2014062938A1 (en) | 2012-10-19 | 2014-04-24 | Bristol-Myers Squibb Company | Rory modulators |
WO2014075874A1 (en) | 2012-11-13 | 2014-05-22 | Syngenta Participations Ag | Microbiocidal pyrazole derivatives |
WO2014075873A1 (en) | 2012-11-13 | 2014-05-22 | Syngenta Participations Ag | Microbiocidal pyrazole derivatives |
-
2013
- 2013-02-01 MX MX2014009355A patent/MX352181B/es active IP Right Grant
- 2013-02-01 WO PCT/IB2013/050870 patent/WO2013114332A1/en active Application Filing
- 2013-02-01 US US14/376,307 patent/US9266876B2/en active Active
- 2013-02-01 JP JP2014555374A patent/JP6073931B2/ja active Active
- 2013-02-01 PL PL13712913T patent/PL2809668T3/pl unknown
- 2013-02-01 BR BR112014018714A patent/BR112014018714A8/pt not_active IP Right Cessation
- 2013-02-01 KR KR1020147024508A patent/KR101800607B1/ko active IP Right Grant
- 2013-02-01 EP EP13712913.6A patent/EP2809668B1/en active Active
- 2013-02-01 SG SG11201404144PA patent/SG11201404144PA/en unknown
- 2013-02-01 MY MYPI2014702122A patent/MY170524A/en unknown
- 2013-02-01 EA EA201400854A patent/EA027595B1/ru not_active IP Right Cessation
- 2013-02-01 UA UAA201409420A patent/UA113638C2/uk unknown
- 2013-02-01 CA CA2861020A patent/CA2861020C/en active Active
- 2013-02-01 AU AU2013216354A patent/AU2013216354B2/en not_active Ceased
- 2013-02-01 CN CN201380007926.7A patent/CN104093715B/zh active Active
- 2013-02-01 ES ES13712913.6T patent/ES2632237T3/es active Active
- 2013-02-01 NZ NZ629795A patent/NZ629795A/en not_active IP Right Cessation
-
2014
- 2014-07-03 PH PH12014501540A patent/PH12014501540B1/en unknown
- 2014-07-30 IL IL233872A patent/IL233872A/en not_active IP Right Cessation
- 2014-07-31 CL CL2014002048A patent/CL2014002048A1/es unknown
-
2015
- 2015-05-08 HK HK15104367.0A patent/HK1203939A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA201400854A1 (ru) | 2015-04-30 |
HK1203939A1 (en) | 2015-11-06 |
EA027595B1 (ru) | 2017-08-31 |
EP2809668B1 (en) | 2017-04-12 |
WO2013114332A1 (en) | 2013-08-08 |
CN104093715B (zh) | 2017-04-26 |
CA2861020C (en) | 2018-07-17 |
CL2014002048A1 (es) | 2014-11-14 |
IL233872A (en) | 2017-05-29 |
BR112014018714A2 (es) | 2017-06-20 |
JP6073931B2 (ja) | 2017-02-01 |
PL2809668T3 (pl) | 2018-02-28 |
MX2014009355A (es) | 2014-09-01 |
CA2861020A1 (en) | 2013-08-08 |
KR20140120364A (ko) | 2014-10-13 |
PH12014501540A1 (en) | 2014-09-22 |
UA113638C2 (xx) | 2017-02-27 |
EP2809668A1 (en) | 2014-12-10 |
US20140371204A1 (en) | 2014-12-18 |
MX352181B (es) | 2017-11-13 |
BR112014018714A8 (pt) | 2017-12-26 |
AU2013216354B2 (en) | 2017-08-31 |
ES2632237T3 (es) | 2017-09-12 |
JP2015506957A (ja) | 2015-03-05 |
AU2013216354A1 (en) | 2014-09-25 |
MY170524A (en) | 2019-08-09 |
KR101800607B1 (ko) | 2017-11-23 |
NZ629795A (en) | 2016-06-24 |
US9266876B2 (en) | 2016-02-23 |
CN104093715A (zh) | 2014-10-08 |
PH12014501540B1 (en) | 2014-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1207069A1 (en) | Heterocyclic compounds and uses thereof | |
HK1199725A1 (en) | Heterocyclic compounds and uses thereof | |
HK1198475A1 (en) | Heterocyclic compounds and uses thereof | |
HK1198443A1 (en) | Heterocyclic compounds and uses thereof | |
HK1193561A1 (zh) | 雜環化合物和其用途 | |
HK1203939A1 (en) | 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives 4-(-2-)- | |
HK1203927A1 (en) | Heterocyclic compounds and uses as anticancer agents | |
HK1210769A1 (en) | Heterocyclic compound | |
EP2889291A4 (en) | HETEROCYCLIC CONNECTION | |
EP2821401A4 (en) | HETEROCYCLIC COMPOUND AND USE THEREOF | |
HK1201521A1 (en) | Heterocyclic compounds and methods for their use | |
EP2873669A4 (en) | HETEROCYCLIC COMPOUND | |
EP2832734A4 (en) | HETEROCYCLIC CONNECTION | |
HK1201533A1 (en) | Heterocyclic compounds and methods for their use | |
HK1201531A1 (en) | Heterocyclic compounds and methods for their use | |
EP2818473A4 (en) | HETEROCYCLIC COMPOUND | |
EP2886546A4 (en) | Heterocyclic compound and use thereof | |
EP2927229A4 (en) | HETEROCYCLIC COMPOUND | |
EP2857400A4 (en) | HETEROCYCLIC COMPOUND | |
AP3611A (en) | Heterocyclic compounds and their uses | |
EP2813508A4 (en) | HETEROCYCLIC COMPOUND AND APPLICATION THEREOF | |
EP2782571A4 (en) | HETEROCYCLIC COMPOUNDS AND USES THEREOF |